These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 30670965)

  • 1. Some Prospective Alternatives for Treating Pain: The Endocannabinoid System and Its Putative Receptors GPR18 and GPR55.
    Guerrero-Alba R; Barragán-Iglesias P; González-Hernández A; Valdez-Moráles EE; Granados-Soto V; Condés-Lara M; Rodríguez MG; Marichal-Cancino BA
    Front Pharmacol; 2018; 9():1496. PubMed ID: 30670965
    [No Abstract]   [Full Text] [Related]  

  • 2. Potential metabolic and behavioural roles of the putative endocannabinoid receptors GPR18, GPR55 and GPR119 in feeding.
    Ramírez-Orozco RE; García-Ruiz R; Morales P; Villalón CM; Villafán-Bernal JR; Marichal-Cancino BA
    Curr Neuropharmacol; 2019; 17(10):947-960. PubMed ID: 31146657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabinoid Receptor-Related Orphan G Protein-Coupled Receptors.
    Irving A; Abdulrazzaq G; Chan SLF; Penman J; Harvey J; Alexander SPH
    Adv Pharmacol; 2017; 80():223-247. PubMed ID: 28826536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationships of imidazothiazinones and analogs as antagonists of the cannabinoid-activated orphan G protein-coupled receptor GPR18.
    Schoeder CT; Kaleta M; Mahardhika AB; Olejarz-Maciej A; Łażewska D; Kieć-Kononowicz K; Müller CE
    Eur J Med Chem; 2018 Jul; 155():381-397. PubMed ID: 29902723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of GPR55 and either cannabinoid CB
    Martínez-Pinilla E; Rico AJ; Rivas-Santisteban R; Lillo J; Roda E; Navarro G; Lanciego JL; Franco R
    Brain Struct Funct; 2020 Sep; 225(7):2153-2164. PubMed ID: 32691218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoid and lipid-mediated vasorelaxation in retinal microvasculature.
    MacIntyre J; Dong A; Straiker A; Zhu J; Howlett SE; Bagher A; Denovan-Wright E; Yu DY; Kelly ME
    Eur J Pharmacol; 2014 Jul; 735():105-14. PubMed ID: 24751709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Update on Non-CB
    Morales P; Reggio PH
    Cannabis Cannabinoid Res; 2017; 2(1):265-273. PubMed ID: 29098189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel cannabinoid receptors.
    Brown AJ
    Br J Pharmacol; 2007 Nov; 152(5):567-75. PubMed ID: 17906678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RAMP and MRAP accessory proteins have selective effects on expression and signalling of the CB
    Glenn NAK; Finlay DB; Carruthers ER; Mountjoy KG; Walker CS; Grimsey NL
    Br J Pharmacol; 2024 Jul; 181(14):2212-2231. PubMed ID: 37085333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Mechanisms of GPR55 Receptor Functional Selectivity during Apoptosis and Proliferation Regulation in Cancer Cells.
    Akimov MG; Gretskaya NM; Dudina PV; Sherstyanykh GD; Zinchenko GN; Serova OV; Degtyaryova KO; Deyev IE; Bezuglov VV
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GPR55 - a putative "type 3" cannabinoid receptor in inflammation.
    Yang H; Zhou J; Lehmann C
    J Basic Clin Physiol Pharmacol; 2016 May; 27(3):297-302. PubMed ID: 26669245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological characterization of GPR55, a putative cannabinoid receptor.
    Sharir H; Abood ME
    Pharmacol Ther; 2010 Jun; 126(3):301-13. PubMed ID: 20298715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. THC Reduces Ki67-Immunoreactive Cells Derived from Human Primary Glioblastoma in a GPR55-Dependent Manner.
    Kolbe MR; Hohmann T; Hohmann U; Ghadban C; Mackie K; Zöller C; Prell J; Illert J; Strauss C; Dehghani F
    Cancers (Basel); 2021 Mar; 13(5):. PubMed ID: 33802282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GPR55, a lysophosphatidylinositol receptor with cannabinoid sensitivity?
    Nevalainen T; Irving AJ
    Curr Top Med Chem; 2010; 10(8):799-813. PubMed ID: 20370712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological evaluation of new constituents of "Spice": synthetic cannabinoids based on indole, indazole, benzimidazole and carbazole scaffolds.
    Schoeder CT; Hess C; Madea B; Meiler J; Müller CE
    Forensic Toxicol; 2018; 36(2):385-403. PubMed ID: 29963207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological evaluation of synthetic cannabinoids identified as constituents of spice.
    Hess C; Schoeder CT; Pillaiyar T; Madea B; Müller CE
    Forensic Toxicol; 2016; 34():329-343. PubMed ID: 27429655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Insights in Cannabinoid Receptor Structure and Signaling.
    Ye L; Cao Z; Wang W; Zhou N
    Curr Mol Pharmacol; 2019; 12(3):239-248. PubMed ID: 30767756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anandamide, Acting via CB2 Receptors, Alleviates LPS-Induced Neuroinflammation in Rat Primary Microglial Cultures.
    Malek N; Popiolek-Barczyk K; Mika J; Przewlocka B; Starowicz K
    Neural Plast; 2015; 2015():130639. PubMed ID: 26090232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of Cannabinoid Receptors in Human Osteoarthritic Cartilage: Implications for Future Therapies.
    Dunn SL; Wilkinson JM; Crawford A; Bunning RAD; Le Maitre CL
    Cannabis Cannabinoid Res; 2016; 1(1):3-15. PubMed ID: 28861474
    [No Abstract]   [Full Text] [Related]  

  • 20. Cannabinoids in Gynecological Diseases.
    Luschnig P; Schicho R
    Med Cannabis Cannabinoids; 2019 Sep; 2(1):14-21. PubMed ID: 34676329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.